Influence of underlying immunosuppression on mortality in patients with VZV pneumonia. (PDF 1968 kb
Supplementary Materials and methods. Table S1. Total numbers of mice analyzed per group per analysis...
Table S5. Factors associated with hospital mortality in immunocompromised patients. Multivariate log...
Table S3. Baseline characteristics for high-risk patients with CAP and HAP (excluding VAP) (ITT popu...
Univariate analysis of patient characteristics associated with hospital mortality. (DOC 39 kb
Highlights / Patient Focus summarizes the content of the study in a form that could be shared with p...
Figure S1. Characteristics of 54Â K. pneumoniae isolates from the non-survival subgroup. (PDF 1596 k...
The receiver operating characteristic curve for the neutrophil differential count in BALF for predic...
Number and proportion of hospitalizations with primary diagnosis of pneumonia, primary sepsis diagno...
Table S1. Univariate analysis for mortality. A univariate Cox regression analyses were employed to i...
Figure S2. This figure shows a Kaplan-Meier curve for hospital survival of immunocompromised patient...
Figure S2. 30-day all-cause mortality (ITT population). a. 30-day all-cause mortality in patients wi...
Detailed characteristics of the patients admitted to ICUs for HSE during the study period. (PDF 81 k...
Figure S1. Flow diagram. Table S1. Description of long-term immunosuppression treatment population. ...
International audienceBackground: Pneumonia is a dreaded complication of varicella-zoster virus (VZV...
Figure S1. Kaplan-Meier curve for hospital survival in immunocompromised patients according to ARDS ...
Supplementary Materials and methods. Table S1. Total numbers of mice analyzed per group per analysis...
Table S5. Factors associated with hospital mortality in immunocompromised patients. Multivariate log...
Table S3. Baseline characteristics for high-risk patients with CAP and HAP (excluding VAP) (ITT popu...
Univariate analysis of patient characteristics associated with hospital mortality. (DOC 39 kb
Highlights / Patient Focus summarizes the content of the study in a form that could be shared with p...
Figure S1. Characteristics of 54Â K. pneumoniae isolates from the non-survival subgroup. (PDF 1596 k...
The receiver operating characteristic curve for the neutrophil differential count in BALF for predic...
Number and proportion of hospitalizations with primary diagnosis of pneumonia, primary sepsis diagno...
Table S1. Univariate analysis for mortality. A univariate Cox regression analyses were employed to i...
Figure S2. This figure shows a Kaplan-Meier curve for hospital survival of immunocompromised patient...
Figure S2. 30-day all-cause mortality (ITT population). a. 30-day all-cause mortality in patients wi...
Detailed characteristics of the patients admitted to ICUs for HSE during the study period. (PDF 81 k...
Figure S1. Flow diagram. Table S1. Description of long-term immunosuppression treatment population. ...
International audienceBackground: Pneumonia is a dreaded complication of varicella-zoster virus (VZV...
Figure S1. Kaplan-Meier curve for hospital survival in immunocompromised patients according to ARDS ...
Supplementary Materials and methods. Table S1. Total numbers of mice analyzed per group per analysis...
Table S5. Factors associated with hospital mortality in immunocompromised patients. Multivariate log...
Table S3. Baseline characteristics for high-risk patients with CAP and HAP (excluding VAP) (ITT popu...